The IPC Virtual Psoriasis Masterclass is designed for early career dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis.
Over the five weekly two-hour sessions of the course, IPC’s world-renowned experts will cover various topics, including the pathogenesis of psoriasis, new and emerging therapies, and how to advocate for your patient.
The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions and question-answer sessions, attendees will obtain practical and important information for their clinical practice.
The IPC Masterclass is open to dermatologists who meet the following criteria:
There is no cost to attend the program, but space is limited. The application deadline is January 22, 2025.
Timezones:
Mauritania/ Senegal: 12:00 – 14:00
Algeria/ Morocco/ Nigeria/ Tunisia: 13:00 – 15:00
Egypt/ Libya/ Rwanda/ South Africa: 14:00 – 16:00
Ethiopia/ Iraq/ Kenya/ Tanzania: 15:00 – 17:00
WELCOME + INTRODUCTION
Mahira El Sayed, MSc, MD, Egypt
Triggers of Psoriasis
Ulrich Mrowietz, MD, Germany
Psoriasis Pathogenesis: Bench to Bedside
Marwa Amer, MD, PhD, Egypt
Presentations of Psoriasis in Skin of Color
Mahira El Sayed, MSc, MD, Egyp
Pustular Psoriasis: Classification and Treatment
Ricardo Romiti, MD, PhD, Brazil
Audience Q & A
Faculty
CLOSING COMMENTS
Marwa Amer, MD, PhD, Egypt
WELCOME + INTRODUCTION
Marwa Amer, MD, PhD, Egypt
Psoriatic Arthritis for Dermatologists
Anna López, MD, PhD, Spain
Diet, Obesity and Psoriasis
Álvaro Gonzalez-Cantero, MD, PhD, Spain
Mental Health and Psoriasis
Maria-Angeliki Gkini, MD, MSc, PhD, FRCP, United Kingdom
Cardiovascular Comorbidities of Psoriasis
Nehal Mehta, MD, MSCE, FAHA, United States
Managing Psoriasis in Patients with Infections
Mona El-Kalioby, MBBCh, MSc, MD, Egypt
Audience Q & A
Faculty
CLOSING COMMENTS
Olusola Ayanlowo, MSc, MD, Nigeria
WELCOME + INTRODUCTION
Olusola Ayanlowo, MSc, MD, Nigeria
How to Treat Patients with Mild Disease
Peter van de Kerkhof, MD, PhD, Netherlands
What to do When Topicals are not Appropriate Anymore: Phototherapy
Fernando Valenzuela, MD, Chile
What to do When Topicals are not Appropriate Anymore: Conventional Systemics
Mohamed El-Komy, MD, Egypt
Management Challenges of Psoriasis in Africans: Biologics & Biosimilars
Tiago Torres, MD, PhD, Portugal
Practical Approach to Managing a Psoriasis Patient
Mahira El Sayed, MSc, MD, Egypt
Audience Q & A
Faculty
CLOSING COMMENTS
Mahira El Sayed, MSc, MD, Egypt
WELCOME + INTRODUCTION
Mahira El Sayed, MSc, MD, Egypt
Psoriasis in Women
Mahira El Sayed, MSc, MD, Egypt
Treating Psoriasis on High-Impact Sites
Mohamed El-Komy, MD, Egypt
Treating Psoriasis in Elderly Patients
Peter van de Kerkhof, MD, PhD, Netherlands
Treating Psoriasis in Pediatric Patients
Kelly Cordoro, MD, United States
Audience Q & A
Faculty
CLOSING COMMENTS
Marwa Amer, MD, PhD, Egypt
WELCOME + INTRODUCTION
Olusola Ayanlowo, MSc, MD, Nigeria
Substandard drugs, Ethnomedicine and Conventional Medicine in Fighting Psoriasis
Giovanni Damiani, MD, PhD, Italy
Management Challenges of Psoriasis in Africans: Methotrexate – The Gains and Challenges
Olusola Ayanlowo, MSc, MD, Nigeria
Challenging Cases by Attendees
All Faculty as Panelists
PROGRAM CLOSING
All Co-Chairs
How can clinicians navigate emotionally complex patient interactions while maintaining empathy and trust? In this article, Mio Nakamura discusses communication approaches that may help strengthen patient relationships in dermatology settings.
Read summaries from the IPC symposium at the 2026 Society for Investigative Dermatology (SID) Annual Meeting covering disease modification, immune pathways, therapeutic escape, and psoriasis treatment response.
In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of systemic corticosteroids in psoriasis. He questions whether they contraindicate the treatment of psoriasis, while also covering his personal experience in prescribing them.
In this Take Ten with IPC video, Professor Peter van de Kerkhof discusses the use and misuse of topical corticosteroids in psoriasis, covering current use, guidelines, and consequences.
Missed the joint symposium hosted by the International Eczema Council (IEC) and International Psoriasis Council (IPC) at the American Academy of Dermatology (AAD) Annual Meeting? Select presentations from Psoriasis or Dermatitis? When Boundaries Blur and Treatments Flip the Script are now available, covering diagnostic overlap, emerging tools, treatment-related reactions, and practical strategies for managing complex cases across diverse patient populations.
